SEC Form 4 · accession 0001640334-26-001231
ARTELO BIOSCIENCES, INC. · ARTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Connie Matsui
Director
Period of report
Jul 17, 2026
Accepted (ET)
Jul 21, 2026 · 6:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001621221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.15 | Jul 17, 2026 | A | 136 | A | — | Jul 17, 2036 | Common Stock | 136 | 136 | D |
Explanation of responses
- F1Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean July 17, 2026.